Literature DB >> 7094018

Target cells infected by avian erythroblastosis virus differentiate and become transformed.

J Samarut, L Gazzolo.   

Abstract

Transformation in vitro of bone marrow cells by avian erythroblastosis virus (AEV) gives rise to rapidly growing cells of erythroid nature. Target cells of neoplastic transformation by AEV are recruited among the early progenitors of the erythroid lineage, the burst-forming units-erythroid (BFU-E). They express a brain-related antigen at a high level and an immature antigen at a low level. We show that AEV-transformed cells express low levels of the brain antigen and high levels of the immature antigen. Their response to specific factors regulating the erythroid differentiation indicates that they are very sensitive to erythropoietin. Furthermore, cells transformed by a temperature-sensitive mutant of AEV differentiate into hemoglobin-synthesizing cells 4 days after being shifted to the nonpermissive temperature. All these properties are similar to those of late progenitors of the erythroid lineage, the colony-forming units-erythroid (CFU-E). These results indicate that the AEV-transformed cells are blocked in their differentiation at the CFU-E stage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094018     DOI: 10.1016/0092-8674(82)90071-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  22 in total

1.  A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias.

Authors:  M Altabef; M Garcia; C Lavau; S C Bae; A Dejean; J Samarut
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Transforming and mitogenic effects of avian leukemia virus E26 on chicken hematopoietic cells and fibroblasts, respectively, correlate with level of expression of the provirus.

Authors:  P Jurdic; M Benchaibi; O Gandrillon; J Samarut
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  The avian erythroblastosis virus erbA oncogene encodes a DNA-binding protein exhibiting distinct nuclear and cytoplasmic subcellular localizations.

Authors:  P Boucher; A Koning; M L Privalsky
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Expression of cytoskeletal protein 4.1 during avian erythroid cellular maturation.

Authors:  N S Yew; H R Choi; J L Gallarda; J D Engel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  AEV-transformed erythroleukemia cell induced differentiation: expression of specific cell membrane antigenic molecules.

Authors:  I Raynaud; J M Biquard; P Chambard; B Fasciotto; J Samarut; J P Blanchet; V Krsmanovic
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Lineage-specific transformation after differentiation of multipotential murine stem cells containing a human oncogene.

Authors:  J C Bell; K Jardine; M W McBurney
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

7.  The chicken c-erbA proto-oncogene is preferentially expressed in erythrocytic cells during late stages of differentiation.

Authors:  D Hentzen; A Renucci; D le Guellec; M Benchaibi; P Jurdic; O Gandrillon; J Samarut
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

8.  Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.

Authors:  A Rascle; N Ferrand; O Gandrillon; J Samarut
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

9.  Expression of the Rous sarcoma virus src gene in avian macrophages fails to elicit transformed cell phenotype.

Authors:  L Lipsich; J S Brugge; D Boettiger
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

10.  Induced differentiation of avian myeloblastosis virus-transformed myeloblasts: phenotypic alteration without altered expression of the viral oncogene.

Authors:  G Symonds; K H Klempnauer; G I Evan; J M Bishop
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.